Blankinship & Foster’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Blankinship & Foster's PFE Position: Q3 2026 in Review
Blankinship & Foster increased its Pfizer (PFE) stake by 0.82% in Q3 2026, buying an estimated $2.37K and bringing the position to 10,940 shares worth $312K. The position accounts for 0.06% of the portfolio, ranked #60.
Blankinship & Foster first reported a position in PFE in Q4 2021 and has held it in 9 quarters since. 2,916 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Blankinship & Foster held 10,940 shares of Pfizer worth $312K as of Q3 2026.
- Blankinship & Foster bought 89 Pfizer shares in Q3 2026, an estimated $2.37K.
- Pfizer made up 0.06% of Blankinship & Foster's portfolio in Q3 2026, its #60 holding.
- Blankinship & Foster first reported a position in Pfizer in Q4 2021 and has held it in 9 quarters since.
- 2,916 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Blankinship & Foster's 13F filing for Q3 2026, filed 19 Oct 2026.